Study shows Tri-Low extract of amla’s efficacy in reducing dyslipidemia
date:Mar 26, 2019
lising its place as an all-powerful cardiac protector even in stubborn cases of unhealthy lipid profiles. Arjuna offers the same nutraceutical in an improved, more bioactive, and highly concentrated form, Anthony said.

Arjunas unique and proprietary, gentle extraction process preserves ingredient functionality and ensures potency.

Amla extracts typically are manufactured from dried amla and can differ fundamentally from Tri-Low in quality and activity. In fact, this was the first study that n
6/8 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/05 04:14